REVA Medical to Hold Briefing Call on Financial Results for Q3 2012
06 November 2012 - 6:01PM
REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a
conference call to discuss the Company's financial results through
September 30, 2012 and its business outlook. Robert Stockman,
Chairman and CEO, will host the call.
The call is scheduled for 2:00 p.m. US PST on Tuesday, November
13, 2012 (or 9:00 a.m. AEDT on Wednesday, 14 November 2012) and may
be accessed within the United States by dialing 1-877-312-5413 five
minutes prior to the scheduled start time. Callers in Australia may
access the call by dialing (02) 8223 9876. If you are asked to
provide an access code, please spell out the word "REVA" to the
operator and you will be connected promptly. A replay of the
audiocast will be available on the Company's website at
www.revamedical.com following the call.
About REVA
REVA is a development stage medical device company incorporated
in Delaware, USA, that is focused on the development and eventual
commercialization of its proprietary bioresorbable stent products.
REVA's initial product, the ReZolveĀ® scaffold, which is in a
clinical study phase, combines REVA's proprietary stent design with
a proprietary polymer that is metabolized and cleared from the
body. The ReZolve scaffold is designed to offer full x-ray
visibility, clinically relevant sizing, and a controlled and safe
resorption rate. In addition, by early encapsulation of the stent
in the artery tissue coupled with the loss of scaffold structure
over time, the ReZolve scaffold may reduce the incidence of late
forming blood clots, or thrombosis, a rare but serious problem
associated with drug-eluting metal stents currently on the market.
REVA will require clinical results and regulatory approval before
it can begin selling the ReZolve scaffold.
The REVA Medical, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=8505
CONTACT: United States
Investor and Media Enquiries:
Cheryl Liberatore
Director, Investor Relations and Marketing
REVA Medical, Inc.
+1 858 966-3045
Australia
Investor Enquiries:
Kim Jacobs or Alan Taylor
Inteq Limited
+61 2 9231 3322
Media Enquiries:
Haley Price or Rebecca Wilson
Buchan Consulting
+61 3 9866 4722
Reva Medical (ASX:RVA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Reva Medical (ASX:RVA)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Reva Medical Inc (Australian Stock Exchange): 0 recent articles
More REVA Medical, Inc. News Articles